Cite
HARVARD Citation
Verstockt ., B. et al. (n.d.). P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort. Journal of Crohn's and colitis. pp. i805-i806. [Online].